Gabelli Funds LLC cut its holdings in WisdomTree, Inc. (NYSE:WT - Free Report) by 18.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 90,000 shares of the company's stock after selling 19,717 shares during the quarter. Gabelli Funds LLC owned 0.06% of WisdomTree worth $803,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Quarry LP grew its holdings in shares of WisdomTree by 1,778.5% during the fourth quarter. Quarry LP now owns 2,799 shares of the company's stock worth $29,000 after buying an additional 2,650 shares in the last quarter. Byrne Asset Management LLC grew its holdings in shares of WisdomTree by 114.0% during the 1st quarter. Byrne Asset Management LLC now owns 3,852 shares of the company's stock worth $34,000 after purchasing an additional 2,052 shares during the period. Versant Capital Management Inc lifted its stake in WisdomTree by 310.5% during the 1st quarter. Versant Capital Management Inc now owns 5,263 shares of the company's stock worth $47,000 after acquiring an additional 3,981 shares in the last quarter. Russell Investments Group Ltd. lifted its stake in WisdomTree by 758.2% during the 1st quarter. Russell Investments Group Ltd. now owns 6,986 shares of the company's stock worth $62,000 after acquiring an additional 6,172 shares in the last quarter. Finally, Personal CFO Solutions LLC acquired a new stake in WisdomTree in the 1st quarter valued at about $111,000. Hedge funds and other institutional investors own 78.64% of the company's stock.
WisdomTree Trading Down 0.0%
WisdomTree stock traded down $0.01 during trading on Wednesday, hitting $13.51. The company's stock had a trading volume of 2,624,779 shares, compared to its average volume of 2,194,075. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 34.63 and a beta of 1.19. The stock's fifty day moving average is $12.92 and its 200 day moving average is $10.43. WisdomTree, Inc. has a 1-year low of $7.47 and a 1-year high of $13.79. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.04 and a current ratio of 1.44.
WisdomTree (NYSE:WT - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.18 EPS for the quarter, hitting the consensus estimate of $0.18. The company had revenue of $112.60 million during the quarter, compared to analyst estimates of $110.66 million. WisdomTree had a return on equity of 25.17% and a net margin of 16.25%.The firm's revenue was up 5.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.16 earnings per share. As a group, equities research analysts predict that WisdomTree, Inc. will post 0.72 EPS for the current year.
WisdomTree Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.03 per share. The ex-dividend date was Wednesday, August 13th. This represents a $0.12 annualized dividend and a yield of 0.9%. WisdomTree's dividend payout ratio is currently 30.77%.
Insider Buying and Selling
In other WisdomTree news, COO R Jarrett Lilien sold 12,500 shares of the company's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $13.21, for a total transaction of $165,125.00. Following the completion of the sale, the chief operating officer directly owned 1,036,138 shares in the company, valued at $13,687,382.98. This represents a 1.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 9.30% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on WT. Oppenheimer increased their price target on WisdomTree from $12.00 to $15.00 and gave the company an "outperform" rating in a research report on Tuesday, July 22nd. Northland Securities set a $16.00 price target on WisdomTree in a research report on Wednesday. Craig Hallum reiterated a "buy" rating on shares of WisdomTree in a research note on Monday, August 4th. Northcoast Research upgraded WisdomTree from a "neutral" rating to a "buy" rating and set a $15.00 target price on the stock in a research note on Wednesday, July 2nd. Finally, Morgan Stanley lifted their price target on WisdomTree from $11.50 to $12.50 and gave the company an "equal weight" rating in a research note on Monday, August 18th. Four analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $13.56.
Check Out Our Latest Stock Report on WisdomTree
WisdomTree Company Profile
(
Free Report)
WisdomTree, Inc, through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.
Featured Stories

Before you consider WisdomTree, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WisdomTree wasn't on the list.
While WisdomTree currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.